Manon Buijs, Diane K. Reyes, Timothy M. Pawlik, Amanda L. Blackford, Riad Salem, Wells A. Messersmith, Colin D. Weekes, Mary Mulcahy, Ihab R. Kamel and Jean-Francois H. Geschwind Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma Cancer 119
Article first published online: 6 NOV 2012 | DOI: 10.1002/cncr.27859
In this single-arm, phase 2 study of patients with unresectable hepatocellular carcinoma, the combination of bevacizumab and transhepatic arterial chemoembolization is safe in carefully selected patients and has antitumor activity.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.